Stay updated with breaking news from Supercon Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Q3 2023 revenues of $742.8 million, up 16.3% year-over-year ; organic revenue up 10.9% yoy Q3 2023 GAAP EPS $0.60; non-GAAP EPS $0.74, up 12.1% yoy Bruker increases FY 2023 revenue guidance to...
Non-GAAP EPS up by 12.1% YoY; FY 2023 Revenue Guidance Increased
Revvity (NYSE:RVTY – Get Rating) and Bruker (NASDAQ:BRKR – Get Rating) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations. Profitability This table compares Revvity and Bruker’s net margins, return on […]
Revvity (NYSE:RVTY – Get Rating) and Bruker (NASDAQ:BRKR – Get Rating) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends. Profitability This table compares Revvity and Bruker’s net margins, return on […]
Standard BioTools (NASDAQ:LAB – Get Rating) and Bruker (NASDAQ:BRKR – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations. Analyst Recommendations This is a summary of recent ratings and price […]